Ollseari on. The gaol of this study was to evaluate the rule or percutaetous auntie vahuleplwty in patients with cardiogenie dioekdmlusav mautiestassieandasooeiatedmajorvomerbid Coedldou rd m eaaalkh peudictsm of atreival.
Barkgrmad. TIM pregmeals for patients in cardlegede shock with aunee elk attitude Is pear. Aortic valve replacement can be OhesrYW, lint the proenee at mdOmgaa Allum precludes thaw pail" tram operation . Peataneeus aortic balloon udtyInphAy hag been and In them patients with short-term hnprosemted mad could be an aheraatire therapeutic option .
Methedr, Of 310 patients mdeegdeg percdaoee o mantic balloon vaholph*, 21 were In emdiugeddc shock and were ladeded h this study. All 21 patients bad associated major =am enadlt at the time of presentation. Retake. After peeesaoeeus amok balloon valraloplmp, systalk antic invasion harmed tram 77 * 3 (seen * SEMI to 116 : 5 mm h g (p = 0.0001): aarek "we am Increased ham 0.45 : 0.04 to 0.3112t 0 .06 00 (P = 0.0001): and Cardiac Index
The prognosis for patients in casdiogenk shock due to critical auntic stenosis is poor. Although emergency sonic valve replacement has been demonstrated to be lifesaving in these patients. it is aeocialed with high surgical morbidity and mortality (1,2), particularly in those patients with advanced age mad associated major medical problems or multiorgan fkflure (3) . or both. Paremaneous aortic balloon valvuloplasty has been performed in patients with critical aortic stenosis R. N. Percumneoas aortic balloon valvuloplasty improved left vestries.
[at function, decreased aortic gradient and incr used aortic valve area (6.7). However, a high restenosis rate (-60% at I year) hampers widespread use of this procedure (5) . Previous studies (9) (10) (11) (12) have reported that preutaneous aortic balloon valvuloplasty ran he prfnrwted success:dly in patients with candiegenic shock and severe aortic stenosis . However, those studies involved a small, relatively youthful number of patients and did not analyze predictors for long term survival. Therefore, the present study was undertaken 10 evaluate the role of prcutaneous sortie balloon valvuloplasty in cardlogenle shock secondary to severe aortic stenosis in a consecutive group of elderly patients who were nonsurgical or very high risk surgical candidates at the time of presentation and to determine predictors for jong-term survival .
Methods
Patient group (Table 1) running on a'Digiml Equipment Carp-microcomputer VAX 3609. Actuarial survival analysis was carried our with the BMDP statistical survival analysis program (19) with the use of the RSII interface to BMDP provided in RSII . Cox proportional hazards models of the eovariates of survival and of survival free of events were constructed with the BMW2L program and were used to identify significant predictors of survival (20). These covariates of survival were selected in a stepwise fashion : only significant (p 0 .05. chi-square analysis) covariates were retained in each model .
Results
Associated coIOrbid conditions . All patients had more than one medical eomorbid condition (average LS) that made them either nonsugical or high risk surgical candidates at the time of presentation (Table 1) . Chronic renal Failure defined as serum cretainine > 1 .5 mg% was present in nine patients (blood urea nitrogen 0 ± 8 nags( ; creatinine 4.25'_ 1 .83 mg56, merge 1 .7 to 15.2). Significant multivesxel coronary artery disease, defined as a X70% decrease in arterial lumen diameter in two angiographic orthogonal views was present in eight patients . Five patients had a history of previous myocardial infraction . and three patients had previously undergone coronary artery bypass graft surgery. Furthermore. I I patients had elevation of creatine bitase (CIO consistent with nau-Q wave myocardial infarction at the time of presentation. Previous stroke was present in three patients, cancer in three and severe chronic obstructive pulmonary disease (forced expiratory volume in 1 s IFEVt) <1 titans) in three. Liver failure, pneumonia, pulnmuwy henmrrhuge. pulmonary embolism and acquired immuoodefideuey syndrome (AIDS) were the other associated medical problems. All patients required i soiropic and presser support at the time od the procedure, and two patients required an iotmaaNc balloon pump after percutatnous aortic balloon valWloplasty.
lie aedtas uric vadahka. The immediate hemodyoamic changes produced by percumneous aortic balloon valvuloplesty are shown in Table 2 . Systolic arterial pressure increased significantly after percutaneous aortic balloon valvubplasty, from 77 ± 3 to 116 -18 mm Rg (p = 0.0001) . Sixteen patients were successfully weaned from isotropic support within the 1st 24 h after the procedure . Mean aortic gradient decreased from 49 a 4 to 21 z 3 mat Its (p -OAOOI), cardiac index increased from 1 .04 ± 0.13 to 2 .24 ± 0.15 Literslmin per m5 (p = 0 .06) ; and aortic valve area increased ftom 0 .48 a 0.04 to 0 .84 ± 0 .06 cars (p m 0.0001) . Because the Gorlio formula is flaw dependent, with "-!ve area incteasiag as flew iacreascs despite a fated orifice valve area, we also used comic valve resistance . With percumneeon sonic balloon valvuloplasy, aortic valve resistance decreased from 1,413'-230 to 524 ± 76 dynepscm ' (p = 0 .001). Left ventricular systolic and end-diastolic, systolic pdmonary artery and right atrial pressures did not change significantly after percutaneous aortic balloon valvuloplasty . Procednrmrelated morbidity and mortality (Table 3) . Tonal hospital mortality rate was 4356 (9 of 21 patients) . Two patients died during the procedure . Both patients had non-Q wave myocardial infarction before percutaneous aortic 'belloon valvuloplasty . At autopsy. one patient had an extensive circumferential subendocardial necrosis with normal coronary arteries . The other patient had severe three-vessel coronary artery disease with occluded coronary artery bypass grafts. severe mitral senosis . mitral and tricuspid regurgitation, a remote transmural anteroapical infarct and a recent inferoposterior and right ventricular tmnsmuml infarct. The myocardium was infected with Listeria mottociIagenes, with cavitation and abscess formation. Seven additional patients died subsequently despite successful percutaneous aortic balloon valvuloplasy (two from congestive heart failure due to a myopathic left ventricle, five from multiotgan failure). Local vascular complications occurred in five patients (24%). two of them related to the use of intraaorlic balloon pump. Three patients (14%) required vascular surgery. One path at developed severe aortic regnrgitation and underwent successful aortic valve replacement 24 h after peremaneous aortic balloon valvuloplasty . The anatomic findings at operation included severe aortic valve rear with disseclion of the sortie annulus and the intervenuicular septum . The patient was discharged from hospital 19 days after percutaaeous aortic balloon valvuloplasty . One patient had no embolic stroke . Cholesterol emboli occurred in one patient . There was elevation of CK . MB fraction, consistent with the presence of myocardial necrosis in I1 patients (53%) . Coronary mtesiogmphy or autopsy demonstrated significant coronary artery disease in seven patients (51%) and normal coronary arteries in three . In the other patient, the coronary arteries were not evaluated .
Follow-up (Rig, 1). Twelve patients (57%) survived (including one patient with aortic valve replacement 24 h after percutaneous aortic balloon valvuloplasty) and were discharged from the hospital with marked improvement at 21 ± 2 days after percutaneous aortic balloon valvuloplasty.
Three additional patients underwent elective aortic valve replacement after discharge . Aortic valve replacement was not performed in the other eight patients . There were five cardiac deaths during a 15 ± 6-month follow-up period . Aortic valve replacement in patients with cardiogenic shock and severe aortic stenosis is associated with high mortality . Hunter et al. (21) reported the results of aortic Valve replacement in patients with severe congestive heart failure or low cardiac output due to aortic valve disease . or both, requiring pressor support at the time ofsurgery . in the subgroup of patients with isolated aortic stenosis . the iD hospital mortality rare Wits 3% . In patients with cardiogenic shock, the in-hospital mortality rate increased to SAM . ISirklin et al . (22) reported a :Y% in-nuspital mortality rate after aortic valve replacement in patients with cardiogenic shock due to severe aortic stenosis, associated Bamcrbid conditions were not addressed in this study.
4apuetant variables effecting early mortality after aortic valve replacement include older age . reduced left ventricular ejection fraction, renal dysfunction and high functional class (3) . Most patients in our study had at the time of presentation at least one of these risk factors, including nine patients with muitiagan falure, making them high risk surgical candidates. Nevertheless, with percutaneous aortic balloon valvulopiasly, 57% of these patients survived soot were discharged from the hospital despite associated major comorbid conditions. Thus, under most adverse circumstances . percutaneous aortic balloon valvulopkLUy can be performed :vith a high initial success rate, allowing stabilization of selected patients for eventual aortic valve replacement .
Study Bridge stone . Despite limitations . such as a retro . sportive design, small number ofpatients. short-term follow-up and the absence of a control group at the time of admission . percutanenus aortic balloon valvultplasty was considered the only possible approach for these very sick, moribund patients.
Cnatludau. 1) Emergency peruutaneaus aortic balloon valvuloplsaty can be performed with a high success rate in patients with Cardiof Hlie shock due to severe aortic stenosis who are not candidates for aortic valve replacement at the time of presentation (owing to the presence of associated major eomorbid conditions). Percutaneous aortic balloon valvuloplasty can be used to stabilize appropriately selected patients (those without ternBmd comorbid conditions) for eventual acetic valve replacement . 2) In this subset of patients with cardiogenic shock and severe sortie stenosis . in-hospital morbidity and mortality remain high, despite successful percutaneous aortic balloon valvuloplasty . 3) A subgroup of patients with a significant increase in :,ardiac Index after percutaneous aortic balloon valvuloplesty may obtain greater benefit from the procedure . 4) For those patients who are aoasurgical or very high risk surgical candidates at the time of presentation, petcutaneous aortic balloon vslvuktplasty may be the only alternative . It is therefore recommended tba :1) percutaneous aortic balloon valvuloplasty, should be performed in patients with cardiogene shock due to severe aortic stenosis who are reonsurgical or very high risk surgical candidates at the time of presentation: and 2) because of the high incidence of restenosis after percutaneous aortic balloon valvuloplasty ; cork valve replacement should always be considered if the patieni s condition Improves after percutaneous aortic balloon valvuloplasty .
